Back to Results
First PageMeta Content
Phenols / Morphinans / Alcohols / Ketones / Ethers / Methadone / Morphine / Opioid / Placebo / Chemistry / Medicine / Organic chemistry


TD-1211 Phase 2b Study Demonstrates Increased Bowel Movement Frequency in Patients with Opioid-induced Constipation Regardless of Baseline Opioid Dose Abstract #1441 Poster #120
Add to Reading List

Document Date: 2014-07-31 12:05:09

Open Document

File Size: 972,24 KB

Share Result on Facebook

City

South San Francisco / Salt Lake City / Pasadena / /

Company

AEs / Baseline Opioid Dose Group / Daniel Canafax1 1 Theravance Inc. / Las Vegas NV / Lotus Clinical Research Inc. / /

/

Event

FDA Phase / /

MedicalCondition

pain / chronic non-cancer pain OIC / chronic cancer / Opioid-induced constipation / chronic non-cancer pain / respiratory depression / constipation / chronic / Back pain / /

MusicGroup

Nausea / /

Position

representative / T.D. / /

Product

Opioid / TD-1211 / /

ProvinceOrState

Utah / California / /

PublishedMedium

Baseline / /

SocialTag